These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32396752)

  • 1. Examination of the effect of niosome preparation methods in encapsulating model antigens on the vesicle characteristics and their ability to induce immune responses.
    Obeid MA; Teeravatcharoenchai T; Connell D; Niwasabutra K; Hussain M; Carter K; Ferro VA
    J Liposome Res; 2021 Jun; 31(2):195-202. PubMed ID: 32396752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.
    Jain S; Singh P; Mishra V; Vyas SP
    Immunol Lett; 2005 Oct; 101(1):41-9. PubMed ID: 15869802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for preparation of niosomes: A focus on thin-film hydration method.
    Thabet Y; Elsabahy M; Eissa NG
    Methods; 2022 Mar; 199():9-15. PubMed ID: 34000392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery.
    Bayindir ZS; Yuksel N
    J Pharm Sci; 2010 Apr; 99(4):2049-60. PubMed ID: 19780133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-ionic surfactant vesicles mediated transcutaneous immunization against hepatitis B.
    Maheshwari C; Pandey RS; Chaurasiya A; Kumar A; Selvam DT; Prasad GB; Dixit VK
    Int Immunopharmacol; 2011 Oct; 11(10):1516-22. PubMed ID: 21609785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonic Processing Technique as a Green Preparation Approach for Diacerein-Loaded Niosomes.
    Khan MI; Madni A; Hirvonen J; Peltonen L
    AAPS PharmSciTech; 2017 Jul; 18(5):1554-1563. PubMed ID: 27604883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of noisome preparation methods in encapsulating 5-fluorouracil and real time cell assay against HCT-116 colon cancer cell line.
    Ugorji OL; Umeh ONC; Agubata CO; Adah D; Obitte NC; Chukwu A
    Heliyon; 2022 Dec; 8(12):e12369. PubMed ID: 36582708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
    Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
    Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and biological evaluation of Gymnema sylvestre extract-loaded nonionic surfactant-based niosomes.
    Kamble B; Talreja S; Gupta A; Patil D; Pathak D; Moothedath I; Duraiswamy B
    Nanomedicine (Lond); 2013 Aug; 8(8):1295-305. PubMed ID: 23259778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microfluidic manufacturing of different niosomes nanoparticles for curcumin encapsulation: Physical characteristics, encapsulation efficacy, and drug release.
    Obeid MA; Khadra I; Albaloushi A; Mullin M; Alyamani H; Ferro VA
    Beilstein J Nanotechnol; 2019; 10():1826-1832. PubMed ID: 31579065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo.
    Wang M; Yuan Y; Gao Y; Ma HM; Xu HT; Zhang XN; Pan WS
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1134-41. PubMed ID: 22182601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
    Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
    Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Effect of a Small Hydrophobic Drug (Cinnarizine) on the Physicochemical Characterisation of Niosomes Produced by Thin-Film Hydration and Microfluidic Methods.
    Yeo LK; Olusanya TOB; Chaw CS; Elkordy AA
    Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30322124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B.
    Vyas SP; Singh RP; Jain S; Mishra V; Mahor S; Singh P; Gupta PN; Rawat A; Dubey P
    Int J Pharm; 2005 May; 296(1-2):80-6. PubMed ID: 15885458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of solvent selection on the characteristics of niosome nanoparticles prepared by microfluidic mixing.
    Obeid MA; Haifawi S; Khadra I
    Int J Pharm X; 2023 Dec; 5():100168. PubMed ID: 36852395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of resveratrol entrapped niosomes for topical use.
    Pando D; Matos M; Gutiérrez G; Pazos C
    Colloids Surf B Biointerfaces; 2015 Apr; 128():398-404. PubMed ID: 25766923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabeling of Preformed Niosomes with [
    Almasi A; Shahhosseini S; Haeri A; Daha FJ; Geramifar P; Dadashzadeh S
    AAPS PharmSciTech; 2018 Nov; 19(8):3859-3870. PubMed ID: 30291544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of EP-liposomes and Span 40-niosomes.
    Ning M; Guo Y; Pan H; Zong S; Gu Z
    Pharmazie; 2006 Mar; 61(3):208-12. PubMed ID: 16599261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new vesicle-loaded hydrogel system suitable for topical applications: preparation and characterization.
    Carafa M; Marianecci C; Di Marzio L; Rinaldi F; Meo C; Matricardi P; Alhaique F; Coviello T
    J Pharm Pharm Sci; 2011; 14(3):336-46. PubMed ID: 21903019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.